Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06578559
Title Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC (BRICKET)
Acronym BRICKET
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gruppo Oncologico del Nord-Ovest
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Istituto Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" Irccs Irst RECRUITING Meldola FC 47014 Italy Details
Fondazione Casa Sollievo Della Sofferenza - Irccs RECRUITING San Giovanni Rotondo FG 71013 Italy Details
IRCCS Istituto Nazionale dei Tumori di Milano RECRUITING Milan MI 20133 Italy Details
Istituto Oncologico Veneto Irccs RECRUITING Padova PD 35128 Italy Details
Azienda Ospedaliero-Universitaria Pisana RECRUITING Pisa PI 56126 Italy Details
Nuovo Ospedale di Prato S. STEFANO RECRUITING Prato PO 59100 Italy Details
AUSL Romagna RECRUITING Ravenna RA 48121 Italy Details
A.O.U. Citta Della Salute E Della Scienza Di Torino Presidio Molinette RECRUITING Turin TO 10126 Italy Details
Azienda Sanitaria Universitaria Friuli Centrale RECRUITING Udine UD 33100 Italy Details
Azienda Ospedaliera Universitaria degli Studi di Campania L. Vanvitelli RECRUITING Naples 80131 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field